interacts with said precursor compound in vivo and converts said precursor
compound into activated form for local delivery,
and wherein said vascular medical device is selected from a
vascular catheter, a vascular stent and a vascular graft.
2
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 Next
Last modified: November 3, 2007